U.S. markets closed
  • S&P 500

    4,188.43
    -44.17 (-1.04%)
     
  • Dow 30

    34,742.82
    -34.94 (-0.10%)
     
  • Nasdaq

    13,401.86
    -350.38 (-2.55%)
     
  • Russell 2000

    2,212.70
    -58.93 (-2.59%)
     
  • Crude Oil

    64.86
    -0.06 (-0.09%)
     
  • Gold

    1,835.90
    -1.70 (-0.09%)
     
  • Silver

    27.37
    -0.11 (-0.40%)
     
  • EUR/USD

    1.2142
    -0.0027 (-0.22%)
     
  • 10-Yr Bond

    1.6020
    +0.0250 (+1.59%)
     
  • GBP/USD

    1.4126
    +0.0136 (+0.97%)
     
  • USD/JPY

    108.8290
    -0.0120 (-0.01%)
     
  • BTC-USD

    56,022.04
    -2,112.12 (-3.63%)
     
  • CMC Crypto 200

    1,484.90
    -76.40 (-4.89%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    29,518.34
    +160.52 (+0.55%)
     

J&J says delaying rollout of COVID-19 vaccine in Europe

  • Oops!
    Something went wrong.
    Please try again later.

April 13 (Reuters) - Johnson & Johnson said on Tuesday it would delay the rollout of its COVID-19 vaccine in Europe and was reviewing cases of extremely rare blood clots in people after they received the shot with European health authorities.

U.S. federal health agencies on Tuesday recommended pausing the use of the COVID-19 vaccine as six women under 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic. (https://bit.ly/3tf2s85) (Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli)